{"public_id":"co_88e5cb61983a46e8a922039a75b27b64","status":"active","merged_into_public_id":null,"resolved_public_id":"co_88e5cb61983a46e8a922039a75b27b64","name":"4-dose series","description":"An infant immunization schedule consisting of four primary doses.","aliases":["Academy schedule"],"types":["immunization schedule"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":35107128,"title":"Trivalent oral poliovirus vaccine: a comparison of two infant immunization schedules.","citation_count":16,"url":"https://sah.borca.ai/papers/35107128"}],"claims":[{"public_id":"cl_0097f69df8d5233f676d43a8e0661b25","text":"The comparative immunogenicity assessment did not show a clear efficacy advantage for either infant immunization schedule.","corpus_id":35107128,"url":"https://sah.borca.ai/claims/cl_0097f69df8d5233f676d43a8e0661b25"},{"public_id":"cl_147c359af5fe0da764cf189c929713f8","text":"Both the 3-dose and 4-dose primary infant immunization schedules produced a satisfactory percentage of infants with microneutralization titers of 1:10 or greater to all three poliovirus types.","corpus_id":35107128,"url":"https://sah.borca.ai/claims/cl_147c359af5fe0da764cf189c929713f8"},{"public_id":"cl_3b9b4df8adb770c085798c875aca9877","text":"Minor differences were observed between the two schedules in the percentage of individuals with titers against poliovirus types 1 and 3 during the study.","corpus_id":35107128,"url":"https://sah.borca.ai/claims/cl_3b9b4df8adb770c085798c875aca9877"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_88e5cb61983a46e8a922039a75b27b64","url":"https://sah.borca.ai/concepts/co_88e5cb61983a46e8a922039a75b27b64"}